仁信新材 reported revenue of ¥1.16B for the period ended 2026-06-30, +4.3% year on year. Net income was ¥-0.11B, a -9.2% net margin on a -4.7% gross margin. The largest revenue line is HIPS at 53% of the total. Free cash flow for the period was ¥-0.03B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.16B | +4.3% |
| Gross profit | ¥-0.05B | — |
| Operating income | ¥-0.11B | — |
| Net income | ¥-0.11B | -540.9% |
| Gross margin | -4.7% | Net margin -9.2% |
| Revenue Q/Q | +49.5% | — |
| Segment | Revenue | Share |
|---|---|---|
| HIPS | ¥0.62B | 53.3% |
| GPPS | ¥0.54B | 46.7% |
| 其他(补充) | ¥0.00B | 0.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥1.21B | 104.7% |
| R&D | ¥0.00B | 0.2% |
| SG&A | ¥0.02B | 1.3% |
| Tax & other | ¥0.00B | 0.1% |
| Item | Amount |
|---|---|
| Total assets | ¥2.29B |
| Total liabilities | ¥0.85B |
| Shareholders' equity | ¥1.44B |
| Equity / assets | 62.9% |
| Operating cash flow | ¥-0.01B |
| Capital expenditure | ¥0.02B |
| Free cash flow | ¥-0.03B |
| Cash conversion (OCF / net income) | 260% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
宏景科技 ・ 溯联股份 ・ 星源卓镁 ・ 英特科技 ・ 华人健康 ・ 安培龙 ・ 协昌科技 ・ 阿莱德 ・ 波长光电 ・ 世纪恒通 ・ 森泰股份 ・ 泓淋电力
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies